# Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-trimester Termination of Pregnancy (14 - 21 Weeks LMP): A Randomized-controlled Double-blinded Trial

> **NCT00784186** · NA · COMPLETED · sponsor: **Gynuity Health Projects** · enrollment: 120 (actual)

## Conditions studied

- Abortion, Induced

## Interventions

- **DRUG:** mifepristone+misoprostol
- **DRUG:** misoprostol
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00784186
- **Lead sponsor:** Gynuity Health Projects
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2014-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00784186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00784186, "Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-trimester Termination of Pregnancy (14 - 21 Weeks LMP): A Randomized-controlled Double-blinded Trial". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00784186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*